drug

LNCB74

1 story · latest Aug 6, 2026

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by NextCure, Inc.

Timeline

NextCure reports Q2 2026 results, moves toward Avere Therapeutics merger

Aug 6Quarterly updateNextCure, Inc.

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.